InsiderTrades

Form 4 for DLB Dolby Laboratories, Inc.

Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-19 · accession 0000950170-25-024984 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-21 2025-02-19 DLB Pendleton Todd SVP, CMO S - Sale+OE $83.75 -18.1K 37.3K -33% -$1.52M
D 2025-02-21 2025-02-19 DLB Pendleton Todd SVP, CMO M - OptEx $71.07 +7,286 55.4K +15% +$517.8K
D 2025-02-21 2025-02-19 DLB Pendleton Todd SVP, CMO M - OptEx $0.00 -7,286 13.4K -35% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-02-19 S D 18,121 $83.75 37,290 D — — (F3) The shares were sold in multiple transactions at prices ranging from $83.41 to $84.19, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. (F1) Shares held following the reported transactions include 37,290 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
2 Common Class A Common Stock 2025-02-19 M A 7,286 $71.07 55,411 D — — (F1) Shares held following the reported transactions include 37,290 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
3 Derivative Employee Stock Option (Right to Buy) 2025-02-19 M D 7,286 $0.00 13,358 D $71.07 · — to 2032-12-15 7,286 Class A Common Stock (F2) This option was granted for a total of 29,143 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2022, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter.